Weiss Multi-Strategy Advisers’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,500	Closed	-$243K	–	674
2017 Q4	$243K	Hold	2,500	–	–	0.01%	527
2017 Q3	$368K	Sell	2,500 -2,050	-45%	-$386K	0.01%	446
2017 Q2	$732K	Buy	4,550 +550	+14%	+$86.4K	0.03%	400
2017 Q1	$637K	Sell	4,000 -900	-18%	-$110K	0.03%	433
2016 Q4	$596K	Hold	4,900	–	–	0.03%	312
2016 Q3	$680K	Buy	4,900 +314	+7%	+$39.9K	0.04%	322
2016 Q2	$832K	Buy	+4,586	New	+$832K	0.06%	282

Other funds holding SYRS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Weiss Multi-Strategy Advisers's SYRS Position: Q1 2018 in Review

Weiss Multi-Strategy Advisers sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q1 2018, closing a stake of 2,500 shares — an estimated $243K sold.

Weiss Multi-Strategy Advisers first reported a position in SYRS in Q2 2016 and held it in 7 quarters. The position peaked at $832K in Q2 2016. 57 funds tracked by Wall St. Rank hold SYRS as of Q1 2018.

Weiss Multi-Strategy Advisers reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 2,500 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2018, an estimated $243K.
Weiss Multi-Strategy Advisers first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q2 2016 and held it in 7 quarters.
Weiss Multi-Strategy Advisers's Syros Pharmaceuticals, Inc. Common Stock position peaked at $832K in Q2 2016.
57 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2018.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2018, filed 15 May 2018.